![Jeffrey Edwards](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Edwards
Directeur/Membre du Conseil chez
KYNTRA BIO, INC.
Fortune : 232 800 $ au 31/05/2026
Profil
Mr. Jeffrey L.
Edwards is an Independent Director at Clearside Biomedical, Inc., an Independent Director at Bio-Rad Laboratories, Inc., an Independent Director at Kyntra Bio, Inc., a Chief Financial Officer, Director & Vice President at Serica Technologies, Inc. and an Independent Director at Viamet Pharmaceuticals Corp.
He is on the Board of Directors at Clearside Biomedical, Inc., Bio-Rad Laboratories, Inc., Kyntra Bio, Inc., MAP Pharmaceuticals LLC, Serica Technologies, Inc., Viamet Pharmaceuticals, Inc. and Viamet Pharmaceuticals Corp.
Mr. Edwards was previously employed as an Independent Director by Lifecore Biomedical, Inc., a Chief Financial Officer & Executive VP-Finance by Allergan, Inc., a Principal by Banque Paribas Belgique SA, and a Principal by Security Pacific National Bank.
He also served on the board at BioTheryX, Inc. He received his undergraduate degree from Muhlenberg College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/04/2026 | 715 ( 0% ) | 223 423 $ | 31/05/2026 | |
KYNTRA BIO, INC. 0,03% | 31/03/2026 | 1 359 ( 0,03% ) | 9 377 $ | 31/05/2026 |
Postes actifs de Jeffrey Edwards
| Sociétés | Poste | Début |
|---|---|---|
| KYNTRA BIO, INC. | Directeur/Membre du Conseil | 28/10/2015 |
| BIO-RAD LABORATORIES, INC. | Directeur/Membre du Conseil | 25/04/2017 |
| CLEARSIDE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 26/09/2018 |
Serica Technologies, Inc.
 Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Directeur Financier/CFO | 25/04/2011 |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Directeur/Membre du Conseil | 01/03/2013 |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Directeur/Membre du Conseil | - |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeffrey Edwards
| Sociétés | Poste | Fin |
|---|---|---|
| LIFECORE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 23/09/2024 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Directeur/Membre du Conseil | 01/05/2021 |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Edwards
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bio-Rad Laboratories, Inc.
 Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
Lifecore Biomedical, Inc.
 Lifecore Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Develops and sells sterile injectable pharmaceutical products | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology Develops therapies and inhalation delivery technologies | Health Technology |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes | Health Technology |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Viamet Pharmaceuticals Corp.
Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry | Health Technology |
Banque Paribas Belgique SA
 Banque Paribas Belgique SA Regional BanksFinance A commercial bank | Finance |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Muhlenberg College
 Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Security Pacific National Bank
 Security Pacific National Bank Major BanksFinance National bank | Finance |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
